AXQ Capital LP Purchases 2,013 Shares of Medtronic PLC $MDT

AXQ Capital LP boosted its Medtronic stake 25.6% in Q2 to 9,890 shares (about $862k), joining several other modest institutional adjustments as institutional investors now own 82.06% of the stock. Shares traded up 1.8% at $101.16; the company has a $129.8bn market cap, P/E of 27.9 and PEG of 2.42, with a 52‑week range of $79.29–$102.59. Insider activity was mixed—a director bought 2,500 shares at $92.37 while an EVP sold 8,605 at $91.58—and analysts have nudged targets higher (average MarketBeat target $109.72; Barclays and Sanford C. Bernstein at $111), reflecting a consensus of moderate buy and suggesting potential upside into the low‑$110s despite low insider ownership (0.26%).

Analysis

AXQ Capital LP increased its Medtronic (MDT) stake 25.6% in Q2 to 9,890 shares, adding 2,013 shares and valuing its position at $862,000; several other hedge funds made only modest adjustments, and institutional investors collectively own 82.06% of shares, indicating concentrated professional ownership. The stock opened at $101.16 on the reported day, trading up 1.8%, and sits near its 52-week high of $102.59 with a market cap of $129.76 billion.

Company fundamentals in the release show a P/E of 27.87, PEG of 2.42 and a beta of 0.77; technicals show a 50-day MA of $95.04 and 200-day MA of $90.94, supporting a medium-term uptrend from the $79.29 52-week low. These metrics imply the market is pricing in measured growth rather than premium expansion, so further upside depends on execution and growth acceleration.

Insider flows were mixed: director William R. Jellison bought 2,500 shares at $92.37 while EVP Harry Skip Kiil sold 8,605 shares at $91.58, reducing his stake by 19.46%; insiders hold only 0.26% of stock. Analyst sentiment is mildly positive with an average MarketBeat target of $109.72, a mix of 13 Buys, 12 Holds and 1 Strong Buy, suggesting consensus upside into the low-$110s but limited margin for disappointment.

Key Decisions for Investors

• Consider adding modest exposure on pullbacks toward the mid-$90s given analyst average target near $110 and technical support at the 50/200-day moving averages
• Monitor insider activity and any follow-up executive selling as a potential signal to trim or hedge positions, particularly because insider ownership is very low at 0.26%
• Size positions with awareness of valuation (P/E ~27.9, PEG 2.42); use partial hedges or smaller initial allocations if relying on growth acceleration to justify higher multiples
• Treat current sentiment as mildly positive but not definitive—hold existing positions for now and consider incremental buys rather than initiating large new positions until further clarity on execution or catalyst arrives